Josephine Tapper

Josephine Tapper

Josephine has provided operational and strategic patient and public engagement and involvement guidance to multiple clinical, policy, regulatory and academic stakeholders for over ten years. She is a long-standing patient member of King’s Improvement Science (KIS) at King’s College London working on various projects including the co-production of departmental patient and public involvement guidelines, mentoring early career researchers and working on quality improvement (QI) projects including urology surgery training and a pre-surgery app. Elsewhere in academia she sits on clinical trial steering committees for digital health innovations and a mixed-methods project researching patient and clinician acceptability of AI in health.

Research interests

Josephine has lived in South East London for over 20 years and is, or has been a patient/service user of multiple King's Health Partners Trusts. She volunteers on a local community farm and has supported older age adults with dual diagnoses of severe and enduring mental health disorders and dementia. She was previously a facilitator for IMPARTS Mind and Body Programme where she first developed a research interest in the benefits of digital health interventions, but also the challenges of implementation.

At a national level Josephine is a lay member of the Medicines and Healthcare Products Regulatory Authority’s (MHRA) Interim Devices Working Group and Expert Advisory Group for Artificial Intelligence, Software and Apps. She is lead panel assessor (patient) for the National Institute of Health and Care Research (NIHR) Artificial Intelligence (A4i), Invention for Innovation and Small Business Research Initiative awards.

Previously Josephine was a lay member of the NHS Valproate Safety Implementation Group concerned with monitoring impact, compliance and patient outcomes of pharmaceutical regulation, a patient-representative advisor on a European Medicines Agency’s (EMA) Pharmaceutical Risk Assessment Committee (PRAC) and the International Urogynaecological Association’s (IUGA) Patient Advisory Council.

Josephine is currently completing an MSc in Medicine, Health and Public Policy at King’s College London and is a fellow of The European Patients’ Academy on Therapeutic Innovation (EUPATI).